Although it has not been reported about PPARγ agonist, a previous study revealed that treatment with GW1929, a selective PPARγ antagonist, enhanced PPARγ mRNA expressions in kidneys from hypertension model rats [28]. The gene discussed is PPARG; the disease is hypertensive disorder.